Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest Articleshsa-miR-125a-5p Enhances Invasion Ability in Non-Small Lung Carcinoma Cell Lines
Chinese Journal of Lung Cancer, 09/22/09
Jiang L et al. – hsa–miR–125a–5p was poorly–expressed in lung cancer cells and it could enhance lung cancer cell invasion by up–regulating hsa–miR–125a–5p.
Related Articles
Treatment after the Failure of Gefitinib in Patients with Advanced or Recurrent Non-small Cell Lung Cancer
Anticancer Research, 11/13/09
Relevance Score: 80%
Phase II Study of Preoperative Gefitinib in Clinical Stage I Non-Small-Cell Lung Cancer
Journal of Clinical Oncology, 11/09/09
Relevance Score: 80%
Elevated serum levels of TPS and CYFRA 21-1 predict poor prognosis in advanced non-small-cell lung cancer patients treated with gefitinib
Medical Oncology, 11/05/09
Relevance Score: 80%
hsa-miR-125a-5p Enhances Invasion in Non-small Cell Lung Carcinoma Cell Lines by Upregulating Rock-1
Chinese Journal of Lung Cancer, 10/20/09
Relevance Score: 80%
An Embryonic Stem Cell–Like Signature Identifies Poorly Differentiated Lung Adenocarcinoma but not Squamous Cell Carcinoma
Clinical Cancer Research, 10/12/09
Relevance Score: 80%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Bronchiolar Progenitor Cells
Proceedings of the American Thoracic Society, 12/04/09
Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis
European Journal of Clinical Investigation, 12/04/09
The Role of Mucus in Cough Research
Lung, 12/03/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non-Small-Cell Lung Cancer
Journal of Clinical Oncology, 12/04/09
Phase I Study of Accelerated Conformal Radiotherapy for Stage I Non-Small-Cell Lung Cancer in Patients With Pulmonary Dysfunction: CALGB 39904
Journal of Clinical Oncology, 12/04/09
Nutrition Aspects of Lung Cancer
Nutrition in Clinical Practice, 12/03/09
Sponsor
Article Search
Sponsor